| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | Director | Ordinary Shares | 462,585 | $5,886,902 | $12.73 | 16 May 2025 | Indirect |
| Centessa Pharmaceuticals plc | Director | Share Option (right to buy) | 40,000 | 20 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 20 Jun 2025 | 1 | $0 | 4 | Director | 24 Jun 2025, 16:13 |
| CNTA | Centessa Pharmaceuticals plc | 15 May 2025 | 2 | +$5,865,242 | 4 | Director | 19 May 2025, 17:49 |
| CNTA | Centessa Pharmaceuticals plc | 25 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 16:34 |
| CNTA | Centessa Pharmaceuticals plc | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:02 |
| CNTA | Centessa Pharmaceuticals plc | 30 Jun 2022 | 1 | $0 | 4 | Director | 05 Jul 2022, 19:00 |
| CNTA | Centessa Pharmaceuticals plc | 01 Jul 2021 | 1 | $0 | 4 | Director | 06 Jul 2021, 19:00 |
| CNTA | Centessa Pharmaceuticals plc | 02 Jun 2021 | 8 | +$49,999,998 | 4 | Director | 04 Jun 2021, 17:00 |
| CNTA | Centessa Pharmaceuticals plc | 27 May 2021 | 0 | $0 | 3 | Director | 27 May 2021, 20:32 |